Search research articles
Contact Us
Filters
Showing results (411-420 of 519) with videos related to
Page
of 52
Sort By:
AIDS and Behavior
|
July 3, 2021
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic Drivers
Hannah Fraser, Annick Borquez, Jack Stone, et al.
The Lancet. Global Health
|
March 30, 2023
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review
Samantha Colledge-Frisby, Sophie Ottaviano, Paige Webb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 25, 2016
Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
Natasha K Martin, Alicia Thornton, Matthew Hickman, et al.
The International Journal on Drug Policy
|
January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence
Sarah Larney, Janni Leung, Jason Grebely, et al.
International Journal of Epidemiology
|
March 7, 2018
Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts
Michelle Taylor, Line Rode, Johan Bjørngaard, et al.
Journal of Hepatology
|
May 13, 2022
Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557]
Alan Yeung, Norah E Palmateer, John F Dillon, et al.
Addiction (Abingdon, England)
|
October 22, 2019
A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations
Neil Goulding, Matthew Hickman, Malcolm Reid, et al.
Journal of Hepatology
|
February 13, 2016
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Natasha K Martin, Peter Vickerman, Gregory J Dore, et al.
Addiction (Abingdon, England)
|
May 19, 2018
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
Zoe Ward, Lucy Platt, Sedona Sweeney, et al.
The Lancet. Psychiatry
|
February 28, 2021
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis
Jack Stone, Louisa Degenhardt, Jason Grebely, et al.
Page
of 52
Search research articles
Search
Showing results (411-420 of 519) with videos related to
Sort By:
Page
of 52
AIDS and Behavior
|
July 3, 2021
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic Drivers
Hannah Fraser, Annick Borquez, Jack Stone, et al.
The Lancet. Global Health
|
March 30, 2023
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review
Samantha Colledge-Frisby, Sophie Ottaviano, Paige Webb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 25, 2016
Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
Natasha K Martin, Alicia Thornton, Matthew Hickman, et al.
The International Journal on Drug Policy
|
January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence
Sarah Larney, Janni Leung, Jason Grebely, et al.
International Journal of Epidemiology
|
March 7, 2018
Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts
Michelle Taylor, Line Rode, Johan Bjørngaard, et al.
Journal of Hepatology
|
May 13, 2022
Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557]
Alan Yeung, Norah E Palmateer, John F Dillon, et al.
Addiction (Abingdon, England)
|
October 22, 2019
A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations
Neil Goulding, Matthew Hickman, Malcolm Reid, et al.
Journal of Hepatology
|
February 13, 2016
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Natasha K Martin, Peter Vickerman, Gregory J Dore, et al.
Addiction (Abingdon, England)
|
May 19, 2018
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
Zoe Ward, Lucy Platt, Sedona Sweeney, et al.
The Lancet. Psychiatry
|
February 28, 2021
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis
Jack Stone, Louisa Degenhardt, Jason Grebely, et al.
Page
of 52